ELITE PHARMACEUTICALS INC Business Finance Contracts & Agreements
43 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Exchange Agreements (2)
- Loan Agreements (6)
- Note Agreements (3)
- Purchase Agreements (13)
- Registration Rights Agreements (4)
- Security Agreements (2)
- Stock Agreements (6)
- Warrant Agreements (5)
- Asset Purchase Agreement, dated June 17, 2024, by and between the Company and Nostrum Laboratories Inc (Filed With SEC on July 1, 2024)
- Loan and Security Agreement, dated April 1, 2022, by and among East West Bank, Elite Pharmaceuticals, Inc. and Elite Laboratories, Inc (Filed With SEC on August 15, 2022)
- Agreement for Sale and Purchase of Real Estate, dated April 8, 2022, by and between Clyde Wesp and Margaret Wesp as trustees of the Wesp Family Joint Living Trust UTD November 19,... (Filed With SEC on August 15, 2022)
- Series J Preferred Stock and Series J Common Stock Purchase Warrant anti-dilution waiver (Filed With SEC on August 14, 2020)
- August 1, 2013, Asset Purchase Agreement between the Company and Mikah Pharma LLC (Filed With SEC on July 31, 2020)
- Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 9, 2020)
- Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 9, 2020)
- Description of Common Stock (Filed With SEC on June 29, 2020)
- Asset Purchase Agreement executed January 16, 2020 by and between the Company and Nostrum Laboratories Inc (Filed With SEC on February 10, 2020)
- Asset Purchase Agreement dated November 13, 2019 by and between the Company and Nostrum Laboratories Inc (Filed With SEC on February 10, 2020)
- August 1, 2013, Asset Purchase Agreement between the Company and Mikah Pharma LLC (Filed With SEC on August 30, 2018)
- May 29, 2018 License, Manufacturing and Supply Agreement with Glenmark Pharmaceuticals Inc. USA. Confidential portions of this exhibit have been redacted and filed separately with... (Filed With SEC on June 14, 2018)
- ASSIGNMENT AGREEMENT (Filed With SEC on June 14, 2017)
- ASSIGNMENT AGREEMENT (Filed With SEC on June 14, 2017)
- ANDA SECURITY AGREEMENT (Filed With SEC on June 14, 2017)
- ELITE PHARMACEUTICALS, INC. AND ELITELABORATORIES, INC. SECURED NOTE DUE 2020 (Filed With SEC on June 14, 2017)
- ASSET PURCHASE AGREEMENT (Filed With SEC on June 14, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 2, 2017)
- PURCHASE AGREEMENT (Filed With SEC on May 2, 2017)
- EXCHANGE AGREEMENT (Filed With SEC on April 28, 2017)
- COMMON STOCK PURCHASE WARRANT ElitePharmaceuticals, inc. (Filed With SEC on April 28, 2017)
- First Amendment to Loan Agreement (Filed With SEC on February 17, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 14, 2014)
- PURCHASE AGREEMENT (Filed With SEC on April 14, 2014)
- ELITEPHARMACEUTICALS, INC. incorporatedunder the laws of the state of nevada SERIES I CONVERTIBLE PREFERRED STOCK (Filed With SEC on February 7, 2014)
- CERTIFICATE OF DESIGNATION of SERIES I CONVERTIBLE PREFERRED STOCK of ELITE PHARMACEUTICALS, INC., (Pursuant to Section 78.1955 of the Nevada Revised Statutes) (Filed With SEC on February 7, 2014)
- ELITE PHARMACEUTICALS, INC. AND ELITELABORATORIES, INC. CONVERTIBLE NOTE DUE 2016 (Filed With SEC on November 26, 2013)
- LOAN AGREEMENT (Filed With SEC on November 14, 2013)
- Amendment No. 2 to Treppel Loan Agreement (Filed With SEC on August 6, 2013)
- ANDA SECURITY AGREEMENT (Filed With SEC on August 5, 2013)
- ELITE PHARMACEUTICALS, INC. AND ELITELABORATORIES, INC. SECURED CONVERTIBLE NOTE DUE 2016 (Filed With SEC on August 5, 2013)
- ASSET PURCHASE AGREEMENT (Filed With SEC on August 5, 2013)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on April 22, 2013)
- PURCHASE AGREEMENT (Filed With SEC on April 22, 2013)
- ELITE PHARMACEUTICALS, INC. incorporatedunder the laws of the state of nevada SERIES G CONVERTIBLE PREFERRED STOCK (Filed With SEC on April 22, 2013)
- ELITE PHARMACEUTICALS, INC. CERTIFICATE OF DESIGNATIONS OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES G PREFERRED STOCK Pursuant to NRS 78.1955 (Filed With SEC on April 22, 2013)
- Amendment No. 1 to Treppel Loan Agreement (Filed With SEC on December 10, 2012)
- LOAN AGREEMENT (Filed With SEC on June 13, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 5, 2012)
- Elite Pharmaceuticals, Inc. Warrant To Purchase Common Stock (Filed With SEC on January 5, 2012)
